SCHEMBL13084019

SCHEMBL13084019

c1ccc(-c2ccc(-c3cc4c(-c5ccc(-c6ccccc6)cc5)cc(-c5ccc(-c6cc(-c7ccccc7)cc(-c7ccccc7)n6)cc5)nc4c4ccccc34)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.49
ACACA Q13085 5/20 0.48
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
HPGD P15428 2/20 0.45
MAPK1 P28482 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
DHODH Q02127 1/20 0.43
MPI P34949 1/20 0.42
TOP1 P11387 2/20 0.41
ACHE P22303 1/20 0.41
MCL1 Q07820 1/20 0.41
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
AURKA O14965 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13083927 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13643386 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13642879 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13643193 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13642823 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13643018 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13642878 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13643124 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13643020 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT
SCHEMBL13642968 1.00 CYP19A1 (0.49) CYP19A1ACACAKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2508585-B1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT EMITTING DIODE CHEIL IND INC (KR) 2016-06-29 EP disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed
EP-2508585-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING ORGANIC LIGHT EMITTING DIODE Cheil Industries Inc. (KR) 2012-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, AOX1, OR10J3 CYP19A1 334/4885ACACA 2421/4885KDM4E 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.